Skip to main content
spacbrain
The briefMonday, 3 August 2026Updated 23:59 GMT

What changed on 3 August 2026

Also on the diary

6 dated events this weekWhat to do about them
  • BYNO Redemption deadline Tue 4 Aug · broker cutoff Fri 31 Jul
  • BYNO Extension vote Wed 5 Aug · broker cutoff Mon 3 Aug
  • BYNO Extension vote Thu 6 Aug · broker cutoff Tue 4 Aug
  • EMCGF Redemption deadline Fri 7 Aug · broker cutoff Wed 5 Aug
  • CCAQ Extension vote Tue 4 Aug · window closed
  • RFAI Redemption deadline Mon 10 Aug · broker cutoff Thu 6 Aug

The window to hand shares back for cash has already closed on these — there is nothing left to claim at the date shown.

Deals


Bluerock to merge with Yellow.ai in a $300M deal

Bluerock agreed to merge with Yellow.ai, an Information Technology company, at a headline value of $300M.

The agreement was announced on Monday 3 August, and we hold no shareholder vote date for it yet.

The companies expect to close in H2 2026.

A $30M PIPE is committed alongside the deal, and the combined company is to trade as YAI.

BLRK dossier The deal 0001213900-26-084282opens on sec.gov in a new tab0001213900-26-087789opens on sec.gov in a new tab0001213900-25-123337opens on sec.gov in a new tab

In the filings


8-K filed 2026-08-03 — AEON Biopharma, Inc., the Priveterra Acquisition Corp. successor, said that on August 3, 2026 it received a letter from NYSE Regulation confirming it…

Why it matters: Sections 1003(a)(i) and (ii) are the stockholders' equity tests, so regaining compliance means the equity deficiency that put the company on the noncompliant list has been cured rather than merely deferred. Removal of the .BC suffix restores normal quoting and takes away the visible distress marker that keeps some brokers and index produ….

AEON dossier 0001837607-26-000057opens on sec.gov in a new tab

8-K filed 2026-08-03 — 8-K of Global Business Travel Group, Inc. Item 5.07 (submission of matters to a vote): at the virtual special meeting on August 3, 2026, stockholders…

Why it matters: Of 522,373,443 Class A shares entitled to vote on the July 6, 2026 record date, 496,040,291 were present or represented, about 94.95%, and the merger carried with under 75,000 votes against. The advisory compensation proposal drew 21 million against, the only meaningful dissent recorded at the meeting. The vote clears the stockholder con….

APSG dossier 0001140361-26-030979opens on sec.gov in a new tab

S-4/A 2026-08-03 — Amendment No. 7 to Registration Statement on Form S-4, containing a preliminary proxy statement/prospectus for an extraordinary general meeting to ap…

Why it matters: The late extension payments and failure to liquidate create material legal and governance risk — a court could determine that Black Hawk was required to liquidate upon expiration of the cure periods, which could invalidate the business combination or lead to shareholder claims. The Debt Forgiveness Agreement reduces the target's receivab….

BKHA dossier 0001829126-26-008251opens on sec.gov in a new tab

425 filed 2026-08-03 — Form 8-K filed as a Rule 425 written communication announcing entry into a definitive Business Combination Agreement between Bluerock Acquisition Cor…

Why it matters: This filing gives investors the complete terms of the proposed deSPAC, including the valuation (pro forma equity ~$550M), the explicit lack of a minimum cash condition (meaning the deal can close even with high redemptions), the aggressive PIPE terms (12% senior secured convertible notes with conversion resets, 5% OID, and 120% prepaymen….

BLRK dossier 0001213900-26-084286opens on sec.gov in a new tab

8-K filed 2026-08-03 — 8-K of The Oncology Institute, Inc. Item 5.03 (amendments to articles of incorporation): on July 28, 2026 the Company filed a Certificate of Amendmen…

Why it matters: An identity change with no economic effect stated: same CUSIP, same rights, new ticker. It matters mainly to anything keyed on the old name or the TOI symbol. The signature block still executes the report as THE ONCOLOGY INSTITUTE, INC. on August 3, after the new name took effect.

DFPH dossier 0001079973-26-000997opens on sec.gov in a new tab

424B4 filed 2026-08-03 — Priced IPO of units at $10.00 raising $100,000,000 ($115,000,000 with full over-allotment). Each unit is one share of common stock plus one right to …

Why it matters: The trust is overfunded at $10.05 per unit, above the $10.00 offering price, so the filed redemption floor begins above par; assuming $10.00 by convention would understate it. The combination window is 12 months from closing, or 15 months if a definitive business combination agreement is entered into within those 12 months. Deferred unde….

EWAV dossier 0001493152-26-035717opens on sec.gov in a new tab

8-K filed 2026-08-03 — This document is an SEC Form 8-K Current Report containing an attached press release, announcing the commencement of separate trading for the company…

Why it matters: Decoupling the units expands secondary market liquidity and enables independent pricing of base equity versus leveraged warrant exposure prior to any de-SPAC transaction. The press release, attributed to company management, confirms the firm continues targeting a business combination within the mining and critical minerals industry. It i….

FDMM dossier 0001213900-26-084273opens on sec.gov in a new tab

DEFM14A filed 2026-08-03 — DEFM14A. The registrant is DEVVSTREAM CORP., an Alberta corporation — the post-combination successor carried on SpacBrain's Focus Impact Acquisition …

Why it matters: Consideration is fixed as percentages rather than share counts: Southern Energy equity converts into XCF Global Class A shares equal to 35% of the XCF Global shares outstanding immediately before the Effective Time, and each DevvStream share into its pro rata portion of a pool equal to 15%. Anticipated post-closing ownership is XCF Globa….

FIAC dossier 0001213900-26-084258opens on sec.gov in a new tab

424B3 filed 2026-08-03 — Definitive 424(b)(3) proxy statement/prospectus (Reg. No. 333-292440) for HVII's merger with ONE Nuclear Energy LLC, setting the extraordinary genera…

Why it matters: The filing discloses the arithmetic plainly: roughly 95.7 million shares, nominally $1.0 billion, for an entity with a $1.8 million net deficit, no revenue and nothing under construction. Trust is accreting to about $10.45 per share, and the August 24, 2026 meeting is the redemption decision point.

HVII dossier 0001493152-26-035869opens on sec.gov in a new tab

8-K filed 2026-08-03 — Intuitive Machines, Inc., the Inflection Point Acquisition Corp. successor, disclosed that on August 3, 2026 its wholly owned subsidiary Intuitive Ma…

Why it matters: A $10 million base cash price is a small, self-funded acquisition rather than a transformational one, so the dilution risk to former IPAX holders is nil — this is paid in cash, not stock. What it buys is ground-segment infrastructure to complement the company's lunar and space services business, which is the vertical-integration path man….

IPAX dossier 0001193125-26-330778opens on sec.gov in a new tab

DEF 14A filed 2026-08-03 — Tevogen Inc. — the successor to Semper Paratus Acquisition Corp, formerly Tevogen Bio Holdings — called its 2026 annual meeting for 24 August 2026, v…

Why it matters: The number that tells the story is the lock-up trigger: shares release only if the price holds $600.00 for 20 of 30 trading days. A threshold that size on a vehicle that IPO'd at $10 is the arithmetic of a large reverse split, i.e. the common has collapsed since the February 2024 close. Also on the record: a $2.0 million advisory fee pai….

LGST dossier 0001493152-26-035757opens on sec.gov in a new tab

12 more not shown (24 in this window).

Redemptions


Nothing to report. No new SEC-sourced redemption results were captured in this window.

New coverage


Nothing to report. No SPACs were added and no decks were extracted in this window.

From the wire

Company wires and the financial press, in this window. Headlines belong to the outlets that wrote them and open on their sites.


The full news feed

How this brief is made


  • Composed deterministically from stored primary-sourced rows — no LLM, no live fetching of facts, $0 per run.
  • Trust NAV accreted at the 3-mo T-bill par yield 4.00% (treasury.gov, 2026-09-10); accreted values are ESTIMATES and labeled as such.
  • Broker action dates count ~2 real NYSE trading days before the deadline (weekends and market holidays excluded) — still verify with your broker, whose cutoff may be earlier.
  • 115 filings were scanned for this window.
  • Dated events are summarised on this page and never turned into an instruction. An outside date is the contractual long-stop: it pays nothing, and the trust comes back only if no combination closes. Where the record holds no dated redemption event either way, the page says so instead of assuming one.

Every figure on this page is taken from a filing with the U.S. Securities and Exchange Commission and links to it. Estimates are labelled as estimates. Prices are last trades, not quotes. This is information, not investment advice.

This is a dated edition — the record of one day, kept at its own address. Editions are retained for 60 days.

Today’s brief